ATN 062 is designed to gain scientific knowledge of microbicide-use adherence, acceptability, and attitudes among sexually active young women
ATN 062 will take place in parallel to another study, MTN 004, "Phase I Study of the Safety and Acceptability of 3% w/w SPL7013 Gel (VivaGel™) Applied Vaginally in Sexually Active Young Women." ATN 062 will use quantitative and qualitative research methods. The quantitative method will consist of a computerized diary used by participants during the 14 days of the gel trial of MTN 004. The qualitative methods will include email messages sent by participants to a research assistant as a supplement to the diaries, as well as in-depth interviews through teleconferences to contextualize the recorded events. All study activities will be timed to coincide with those of MTN 004
Study Type
OBSERVATIONAL
Enrollment
59
Participants will use a computerized phone diary to describe their experiences with the study product during the 14 days of the trial. They will have three teleconferences with "Juliana" to discuss the product and the technology used in the study. They will also have the opportunity to send emails to "Juliana" during the course of the study.
Participants will use a computerized phone diary to describe their experiences with the study product during the 14 days of the trial. They will have three teleconferences with "Juliana" to discuss the product and the technology used in the study. They will also have the opportunity to send emails to "Juliana" during the course of the study.
University of South Florida College of Medicine
Tampa, Florida, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
University Pediatric Hospital
San Juan, Puerto Rico
Microbicide use adherence as measured by a computerized phone diary
Time frame: 21 days(through end of study)
Microbicide use adherence as measured by e-mail messages
Time frame: 21 days (through end of study)
Microbicide use adherence as measured by in-depth interviews via teleconference
Time frame: 21 days (through end of study)
Microbicide use acceptability as measured by a computerized phone diary
Time frame: 21 days (through end of study)
Microbicide use acceptability as measured by e-mail messages
Time frame: 21 days (through end of study)
Microbicide use acceptability as measured by in-depth interviews via teleconferences
Time frame: 21 days (through end of study)
Microbicide use attitudes as measured by a computerized phone diary
Time frame: 21 days (through end of study)
Microbicide use attitudes as measured by e-mail messages
Time frame: 21 days (through end of study)
Microbicide use attitudes as measured by in-depth interviews via teleconferences
Time frame: 21 days (through end of study)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Participants will use a computerized phone diary to describe their experiences with the study product during the 14 days of the trial. They will have three teleconferences with "Juliana" to discuss the product and the technology used in the study. They will also have the opportunity to send emails to "Juliana" during the course of the study.